Sen­a­tors call on HHS to in­ves­ti­gate McK­in­sey's al­leged ties with FDA, opi­oid man­u­fac­tur­ers

McK­in­sey may be in even deep­er trou­ble than it seemed last year. Last sum­mer, Sen­ate De­moc­rats called on the FDA to look in­to ac­cu­sa­tions that the con­sult­ing firm failed to dis­close po­ten­tial con­flicts of in­ter­est as it worked with both the reg­u­la­to­ry agency and opi­oid man­u­fac­tur­ers at the same time.

Un­sat­is­fied with the an­swers they got, the law­mak­ers are now turn­ing to the HHS’ in­spec­tor gen­er­al for some res­o­lu­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER